The article provides information on a study which analyzed the ability of allylselenopyridazine derivatives and other synthetic compounds to inhibit the growth of human breast cancer MCF-7 Cell lines. Topics discussed include organoselenium analogs of pyridazine, cell counting kit (CCK)-8 assays performed, and allicin sulfur compounds.